Results 41 to 50 of about 12,603 (200)

A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.

PLoS ONE, 2012
ObjectiveTo examine the efficacy of ziprasidone vs. placebo for the depressive mixed state in patients with bipolar disorder type II or major depressive disorder (MDD).Methods73 patients were randomized in a double-blinded, placebo-controlled study to ...
Ashwin Patkar, William Gilmer, Chi-un Pae, Paul A Vöhringer, Michael Ziffra, Edward Pirok, Molly Mulligan, Megan M Filkowski, Elizabeth A Whitham, Niki S Holtzman, Sairah B Thommi, Tanya Logvinenko, Antony Loebel, Prakash Masand, S Nassir Ghaemi   +14 more
doaj   +1 more source

Potentiometric Assay of Antipsychotic Drug (Ziprasidone Hydrochloride) in Pharmaceuticals, Serum and Urine

International Journal of Electrochemical Science, 2011
The membranes of ziprasidone hydrochloride-tetraphenyl borate, (Zp-TPB), chlorophenyl borate (Zp-ClPB), phosphotungstate (Zp3-PT), ion associations as molecular recognition reagent dispersed in PVC matrix with dibutylphthalate as plasticizer have been ...
Vinod K. Gupta, Shilpi Agarwal, Barkha Singhal   +2 more
doaj   +1 more source

Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil [PDF]

, 2018
Background: Schizophrenia is associated with significant economic burden. In Brazil, antipsychotics drugs, outpatient and hospital services are provided by the Brazilian National Health System for patients with schizophrenia.
Acurcio, Francisco de Assis, Barbosa, Wallace Breno, Barbui, Corrado, Bennie, Marion, Costa, Juliana de Oliveira, de Oliveira, Helian Nunes, Godman, Brian, Gomes, Rosangela Maria, Jr, Guerra Augusto Afonso, Pires de Lemos, Livia Lovato, Ruas, Cristina Mariano   +10 more
core   +2 more sources

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers

Pharmaceuticals, 2023
The feasibility of using lipid–polymer hybrid (LPH) nanocarriers as a potential platform for the intranasal delivery of ziprasidone (ZP), a second-generation antipsychotic, was explored.
Hadel A. Abo El-Enin, Alaa S. Tulbah, Hany W. Darwish, Rania Salama, Ibrahim A. Naguib, Heba A. Yassin, Hend Mohamed Abdel-Bar   +6 more
doaj   +1 more source

Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis [PDF]

, 2006
It is unusual for acute disseminated encephalomyelitis and multiple sclerosis to present as purely psychiatric disorders. We report five patients with such demyelinating diseases and symptoms of psychosis, depression or anxiety.
Brinar, Marko, Brinar, Vesna V., Habek, Mario, Poser, Charles M.   +3 more
core   +1 more source

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study

Child and Adolescent Psychiatry and Mental Health, 2009
Objective The objective of this study was to compare intramuscular (IM) ziprasidone to conventional IM medications (haloperidol combined with lorazepam) for the treatment of severe agitation in adolescents (age 12–17).
Klotz Steven G, Southard Robert, Preval Horacio, Jangro William C, Francis Andrew   +4 more
doaj   +1 more source

Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study

Molecules, 2020
Schizophrenia is a severe, chronic mental illness characterized by delusions, hallucinations, negative symptoms, and cognitive dysfunction. Recently, several studies have demonstrated that the pathogenesis of schizophrenia involves mitochondrial ...
Kazuki Terada, Ayumi Murata, Erina Toki, Shotaro Goto, Hirofumi Yamakawa, Shuichi Setoguchi, Daisuke Watase, Mitsuhisa Koga, Jiro Takata, Kazuhisa Matsunaga, Yoshiharu Karube   +10 more
doaj   +1 more source

Systemic medications associate with surgically treated cataract among adults over 50 years in Finland

Acta Ophthalmologica, EarlyView.
Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen, Jari Haukka, Tuomas Lilius, Sirpa Loukovaara   +3 more
wiley   +1 more source

ZIPRASIDONE: A NEW ATYPICAL ANTIPSYCHOTIC AGENT

Psychiatry and Clinical Psychopharmacology, 2021
Ziprasidone is a benzisothiazol piperazine derivative with a higher therapeutic efficacy and a favourable tolerability profile in the treatment of schizophrenia. Ziprasidone has a high 5-HT2 to D2 receptor binding ratio and also binds with high affinity
Artuner Deveci, Ayşen Esen Danacı
doaj